2000•Lung CancerRequires access

Phase II study of Gemcitabine, Ifosfamide plus Vinorelbine (GIN) as a first-line chemotherapy in advanced non-small cell lung cancer (NSCLC): A promising non-cisplatin based regimen

Daniel Castellano, P. Lianes, Alberto Arcediano, Carlos Gómez-Martín, Eva Ciruelos, Susana Bezares, María L. Amador, Luis Paz‐Ares, H. Cortés-Funes

Open publisher page 1 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Vinorelbine, Gemcitabine, Medicine, Ifosfamide, Cisplatin, Oncology, Regimen, Chemotherapy

Back to paper search Browse research topics Original source

Phase II study of Gemcitabine, Ifosfamide plus Vinorelbine (GIN) as a first-line chemotherapy in advanced non-small cell lung cancer (NSCLC): A promising non-cisplatin based regimen — Research Paper | ScholarLens